Rabies immune globulin
Highest phase reached
Phase 3
Drug type
Unknown
- Listing at source
- Listed
- Highest phase reached
- Phase 3
- Drug type
- Unknown
- Drug name
- Rabies immune globulin
- imogam
- Imogam
- hrig
- HRIG
- HRIG (HyperRab)
- human polyclonal rabies immune globulin (HRIG)
- Human rabies globulin (hrig)
- human rabies globulin hrig
- Human Rabies Immune Globulin (HRIG)
- Human Rabies Immunoglobulin (HRIG)
- Human Rabies Immunoglobulin(HRIG)
- Human Rabies Immunoglobulins (HRIG)
- hyperrab
- Hyperrab
- HyperRAB
- kamrab
- Kamrab
- Rabies Human Immunoglobulin (HRIG)
- rabies immune globulin
- Rabies immune globulin
- Rabies immune globulin (human)
- rabies immune globulin human
- Rabies immune globulin human
- Rabies immune globulin, human
- Rabies immune globulin,human
- rabies immunoglobulin
- Rabies immunoglobulin
And 2 more, listed on the interactive page.
- ATC classification codes
- J06BB05
Sources for recorded values
- ChEMBL ID
- CHEMBL1201600
- RxNorm IDs (RxCUI)
- 89886
- First in class
- No
- Orphan designation
- No
- Drug name stem
- -bulin
- Condition
- Infections
- Highest recorded phase
- 3
- Condition identifier
- EFO:0000544
- Subject identifier
- D007239
- Condition
- Rhabdoviridae Infections
- Highest recorded phase
- 3
- Condition identifier
- EFO:0007469
- Subject identifier
- D018353
- Condition identifier
- EFO_0000544
- Highest recorded phase
- 3
- Condition identifier
- EFO_0007469
- Condition identifier
- MONDO_0004355
- Condition identifier
- MONDO_0004355
- Highest recorded phase
- 2
- Event
- immune thrombocytopenic purpura
- Reports
- 6
- Reporting signal score
- 34.7916
- Event
- product appearance confusion
- Reports
- 4
- Reporting signal score
- 29.0217
- Event
- product label confusion
- Reports
- 2
- Reporting signal score
- 10.8048
- Event
- product packaging confusion
- Reports
- 2
- Reporting signal score
- 11.4938
- NCT01228383
- NCT02912845
- NCT03145766
- NCT03961555
- NCT02177032
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (22)
- A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines
- A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody
- A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety
- A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects
- Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies
- Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response
- Immunogenicity and Safety of a Purified Vero Rabies Vaccine
- Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies
- Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials
- Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy Adults
- Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents
- Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects
- Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age
- Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects.
- Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1
- Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland
- Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults
- Study to Evaluate GR1801's Efficacy and Safety
- Survey of Human Rabies Immune Globulin Safety in Children
In development for (1)
- Rhabdoviridae infectious disease Phase 3
Other linked conditions (1)
- Childhood leukemia